&Partners’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$43.8K Buy
+10,616
New +$36K ﹤0.01% 2635

Other funds holding RXRX

&Partners's RXRX Position: Q3 2026 in Review

&Partners opened a new position in Recursion Pharmaceuticals (RXRX) in Q3 2026: 10,616 shares worth $43.8K. The stake represents ﹤0.01% of the portfolio and ranks #2635 among its holdings.

352 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.

  • &Partners held 10,616 shares of Recursion Pharmaceuticals worth $43.8K as of Q3 2026.
  • Recursion Pharmaceuticals was a new &Partners position in Q3 2026.
  • Recursion Pharmaceuticals made up ﹤0.01% of &Partners's portfolio in Q3 2026, its #2635 holding.
  • 352 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.

Based on &Partners's 13F filing for Q3 2026, filed 16 Nov 2026.